Department of Radiation Oncology(NCKUH)

Medicine & Life Sciences

1. Head and Neck Neoplasms 100%
2. Survival 64%
3. Radiotherapy 55%
4. Esophageal Squamous Cell Carcinoma 53%
5. Chemoradiotherapy 46%
6. Neoplasms 37%
7. Radiation 31%
8. Triple Negative Breast Neoplasms 29%
9. Squamous Cell Carcinoma 28%
10. Intensity-Modulated Radiotherapy 23%
11. Alcohols 22%
12. Nasopharyngeal Carcinoma 20%
13. Drug Therapy 20%
14. Alcohol Drinking 18%
15. Neck 17%
16. Oropharyngeal Neoplasms 17%
17. Copper Transporter 1 16%
18. Hypopharyngeal Neoplasms 16%
19. Platinum 15%
20. Fluorodeoxyglucose F18 15%
21. Confidence Intervals 15%
22. Therapeutics 14%
23. Mouth 13%
24. Non-Small Cell Lung Carcinoma 12%
25. Catenins 12%
26. Mouth Neoplasms 12%
27. Odds Ratio 12%
28. Genetic Polymorphisms 11%
29. Positron Emission Tomography Computed Tomography 11%
30. Long Noncoding RNA 10%
31. Tobacco Products 10%
32. Carcinogenesis 10%
33. Life Style 9%
34. Lymph Nodes 9%
35. Glioblastoma 9%
36. Tomography 9%
37. Serum 9%
38. Nasopharyngeal Neoplasms 8%
39. MicroRNAs 8%
40. Stomach Neoplasms 8%
41. Hypersensitivity 7%
42. Brain 7%
43. Hepatocellular Carcinoma 7%
44. Prostatic Neoplasms 7%
45. Metal Nanoparticles 7%
46. Adjuvant Chemoradiotherapy 7%
47. Tumor Burden 7%
48. Temozolomide 7%
49. Radium 7%
50. Monocrotaline 6%
51. Esophageal Fistula 6%
52. Anaplastic Thyroid Carcinoma 6%
53. Spine 6%
54. Survival Rate 6%
55. Registries 6%
56. Cell Plasticity 6%
57. Adjuvant Chemotherapy 6%
58. Keloid 6%
59. Genes 6%
60. Pharmaceutical Preparations 6%
61. Thyroid Gland 6%
62. Bone and Bones 6%
63. Drug and Narcotic Control 6%
64. Endosonography 6%
65. Papillomaviridae 5%
66. Prealbumin 5%
67. Sorafenib 5%
68. Stem Cells 5%
69. Nomograms 5%
70. Osteopontin 5%
71. Pericardial Effusion 5%
72. Pulmonary Arterial Hypertension 5%
73. Human papillomavirus 16 5%
74. Reactive Oxygen Species 5%
75. Down-Regulation 5%
76. Neoadjuvant Therapy 5%
77. Vegetables 5%
78. Frailty 5%
79. Machine Learning 5%
80. Genotype 5%
81. Endometrial Neoplasms 5%
82. Squamous Cell Carcinoma of Head and Neck 5%
83. Castration 5%
84. Radiosurgery 5%